Serum B-type natriuretic peptide on admission can predict the ‘no-reflow’ phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction
2010 ◽
Vol 141
(2)
◽
pp. 175-181
◽
2010 ◽
Vol 55
(10)
◽
pp. A104.E971
2018 ◽
Vol 71
(16)
◽
pp. S59
2007 ◽
Vol 100
(4)
◽
pp. 631-634
◽
2016 ◽
Vol 17
(3)
◽
pp. 151-154
◽
2010 ◽
Vol 56
(13)
◽
pp. B42
2021 ◽
Vol 49
(2)
◽
pp. 167-170